A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of UISH001 for the Symptomatic Improvement of Urinary Incontinence.

Trial Profile

A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of UISH001 for the Symptomatic Improvement of Urinary Incontinence.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs UISH 001 (Primary)
  • Indications Urinary incontinence
  • Focus Therapeutic Use
  • Sponsors Beech Tree Labs
  • Most Recent Events

    • 07 Nov 2012 Primary endpoint 'Urinary-leaks' has been met, according to a Beech Tree Labs media release.
    • 25 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
    • 25 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top